adyn Email Format
Biotechnology ResearchWashington, United States2-10 Employees
adyn, a biotechnology research company based in Seattle, Washington, focuses on personalizing birth control to minimize side effects by integrating an individual’s genetic risk and hormone profile. Founded by Dr. Elizabeth Ruzzo and launched in May 2022, the firm aims to help people select the most suitable contraceptive option while reducing adverse reactions, addressing a gap in biological understanding of how individuals respond differently to methods of birth control. The company operates in a scientific space that combines medical history, personal preferences, and biological data to guide contraception choices, with an emphasis on user participation in anonymous research through The Birth Control Test.